Clinical trial
A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected…
NCT00296504 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00296504 |
|---|---|
| Title | A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects |
| Official title | An Open-Label Phase III Study to Assess the Long Term Safety Profile of GW433908 Containing Regimens in HIV-1 Infected Subjects |
| Lead sponsor | ViiV Healthcare, Industry |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infection, Human Immunodeficiency Virus |
| Intervention type | Drug |
| Interventions | fosamprenavir (GW433908), ritonavir |
| Enrollment | 753 |
| Start date | Nov 1, 2001 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Feb 27, 2006 |
| Last update posted | Apr 19, 2013 |
| Countries | Brazil, Chile, France, Italy, Portugal, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: